BFRIライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:27):

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States...

Stats
本日の出来高	29 123.00
平均出来高	794 819
時価総額	8.40M
EPS	$0 ( 2024-03-18 )
次の収益日	( $-1.630 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.130
ATR14	$0.0120 (0.73%)

Insider Trading

Date	Person	Action	Amount	type
2023-07-03	Lanckriet Heikki	Buy	0
2023-05-18	Monaco Erica L.	Buy	76 336	Common Stock
2023-05-18	Monaco Erica L.	Sell	76 336	Restricted Stock Units
2023-05-18	Luebbert Hermann	Buy	95 420	Common Stock
2023-05-18	Luebbert Hermann	Sell	95 420	Restricted Stock Units

INSIDER POWER
25.73
Last 24 transactions
Buy: 1 247 993 \| Sell: 171 756

ボリューム相関

長: -0.20 (neutral)

短: 0.38 (neutral)

Signal:(56.656) Neutral

Biofrontera Inc. 相関

10 最も正の相関
NAKD	0.956
TRIT	0.953
AVIR	0.946
RMRM	0.933
ALXO	0.932
LSXMK	0.932
LSXMA	0.932
IMV	0.931
STRO	0.928
ATSG	0.927

10 最も負の相関
TGTX	-0.945
SLMBP	-0.942
PAE	-0.941
ATRS	-0.941
MEOH	-0.94
DHCAU	-0.938
IDCC	-0.936
PRAA	-0.936
PDFS	-0.933
ANSS	-0.933

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Biofrontera Inc. 相関 - 通貨/商品

-0.29
( neutral )

-0.25
( neutral )

0.00
( neutral )

-0.15
( neutral )

Biofrontera Inc. 財務諸表

Annual	2023
収益:	$34.07M
総利益:	$15.56M (45.68 %)
EPS:	$-13.02

FY	2023
収益:	$34.07M
総利益:	$15.56M (45.68 %)
EPS:	$-13.02

FY	2022
収益:	$28.67M
総利益:	$13.49M (47.04 %)
EPS:	$-0.610

FY	2021
収益:	$24.04M
総利益:	$11.30M (47.00 %)
EPS:	$-3.25

Financial Reports:

No articles found.

Biofrontera Inc.

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.